Jefferies Says Pfizer/Anacor Deal Could Re-Ignite Specialty Pharma M&A; Names Several Potential Targets
Tweet Send to a Friend
Jefferies analyst David Steinberg said Pfizer's (NYSE: PFE) takeover for Anacor Pharma (NASDAQ: ANAC) could be a bellwether for a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
